We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
-$36.6M
Cap. Flow
-$73.8M
Cap. Flow %
-0.42%
Top 10 Hldgs %
30.57%
Holding
716
New
41
Increased
319
Reduced
225
Closed
41

Top Buys

Rank Stock Value
1
WM icon
Waste Management
WM
+$59.7M
2
MSFT icon
Microsoft
MSFT
+$55.1M
3
MA icon
Mastercard
MA
+$53.2M
4
LRCX icon
Lam Research
LRCX
+$52M
5
WMT icon
Walmart Inc
WMT
+$52M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$71.1M
2
UNH icon
UnitedHealth
UNH
+$65.8M
3
AMGN icon
Amgen
AMGN
+$58M
4
IQV icon
IQVIA
IQV
+$50.8M
5
CSCO icon
Cisco
CSCO
+$40.3M

Sector Composition

Rank Sector Weight
1 Technology 33.5%
2 Healthcare 24.06%
3 Financials 11.65%
4 Consumer Discretionary 8.41%
5 Industrials 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTR icon
451
Ventas
VTR
$47.5B
$2.5M 0.01%
42,482
+2,321
+6% +$146K
CLX icon
452
Clorox
CLX
$12B
$2.5M 0.01%
15,376
+2,179
+17% +$356K
NLY icon
453
Annaly Capital Management
NLY
$17.3B
$2.49M 0.01%
136,146
+20,821
+18% +$407K
ENS icon
454
EnerSys
ENS
$6.43B
$2.49M 0.01%
26,930
+7,394
+38% +$720K
GWRE icon
455
Guidewire Software
GWRE
$13.9B
$2.48M 0.01%
14,708
-69,819
-83% -$13M
RMD icon
456
ResMed
RMD
$31.1B
$2.45M 0.01%
10,733
+630
+6% +$152K
HDB icon
457
HDFC Bank
HDB
$123B
$2.45M 0.01%
76,760
-37,240
-33% -$1.19M
STZ icon
458
Constellation Brands
STZ
$22.5B
$2.44M 0.01%
11,037
+88
+0.8% +$20.9K
CNI icon
459
Canadian National Railway
CNI
$78.5B
$2.43M 0.01%
23,900
-3,060
-11% -$335K
MNST icon
460
Monster Beverage
MNST
$95.1B
$2.42M 0.01%
46,135
+9,919
+27% +$526K
VMC icon
461
Vulcan Materials
VMC
$36.8B
$2.41M 0.01%
9,386
+297
+3% +$79.9K
DD icon
462
DuPont de Nemours
DD
$18.6B
$2.41M 0.01%
25,208
+991
+4% +$103K
LEN icon
463
Lennar Class A
LEN
$20.4B
$2.41M 0.01%
18,231
+5,906
+48% +$960K
GEHC icon
464
GE HealthCare
GEHC
$32.7B
$2.41M 0.01%
30,777
-4,165
-12% -$354K
KVUE icon
465
Kenvue
KVUE
$38B
$2.4M 0.01%
112,627
+7,063
+7% +$160K
ERII icon
466
Energy Recovery
ERII
$420M
$2.4M 0.01%
162,976
+10,744
+7% +$184K
MLM icon
467
Martin Marietta Materials
MLM
$34.2B
$2.39M 0.01%
4,627
GPN icon
468
Global Payments
GPN
$24.1B
$2.38M 0.01%
21,246
+2,670
+14% +$292K
HSY icon
469
Hershey
HSY
$37.3B
$2.37M 0.01%
13,997
+2,194
+19% +$393K
ADM icon
470
Archer Daniels Midland
ADM
$38.7B
$2.33M 0.01%
46,210
+13,466
+41% +$729K
NOMD icon
471
Nomad Foods
NOMD
$1.77B
$2.32M 0.01%
138,366
WBD icon
472
Warner Bros
WBD
$64.3B
$2.3M 0.01%
217,843
+53,367
+32% +$496K
ZBH icon
473
Zimmer Biomet
ZBH
$18.8B
$2.3M 0.01%
21,769
+4,336
+25% +$465K
IFF icon
474
International Flavors & Fragrances
IFF
$20.3B
$2.3M 0.01%
27,177
+5,374
+25% +$505K
WST icon
475
West Pharmaceutical
WST
$23.7B
$2.28M 0.01%
6,975
+823
+13% +$259K

Similar funds

Candriam SCA's Q4 2024 Portfolio in Review

As of Q4 2024, Candriam SCA held 716 positions worth $17.4B, down 0.21% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q4 2024 filing shows 41 new, 319 increased, 225 reduced and 41 closed positions. Its largest new stake was Lam Research: 685,631 shares worth $49.5M. The largest sale was Alphabet (Google) Class A, an estimated $71.1M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2024 buy was Lam Research: 685,631 shares worth $49.5M.
  • Candriam SCA added most to Waste Management in Q4 2024, an estimated $59.7M increase.
  • Candriam SCA's biggest Q4 2024 reduction was Alphabet (Google) Class A, cutting an estimated $71.1M.
  • Candriam SCA fully exited Kanzhun in Q4 2024, selling an estimated $22.5M.
  • Candriam SCA's ten largest holdings make up 31% of its $17.4B portfolio in Q4 2024.
  • Candriam SCA opened 41 new positions and closed 41 in Q4 2024.
  • Candriam SCA's portfolio value fell 0.21% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q4 2024, filed 7 Feb 2025.